Changes in gene expression of ARPE-19 cells in response to vitreous treatment

Ophthalmic Research

Volumn 34, Issue 6, 2002, Pages 357-365

  Fan, Wei ^a   Zheng, Jing Juan ^a   Peiper, Stephen C ^b   McLaughlin, Barbara J ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Monocyte chemotactic protein 1; Retinal pigment epithelial cells; Vitreous

Indexed keywords

GENE PRODUCT; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; QUANTITATIVE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; VITREORETINOPATHY;

CELL LINE; CELLS, CULTURED; CHEMOKINE CCL2; DNA PRIMERS; DOWN-REGULATION; EYE PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION; VITREOUS BODY;

EID: 0036977416     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067048     Document Type: Article

References (44)

1. Campochiaro PA: Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 1997;115:237-241.
2. Nagasaki H, Shinagawa K, Mochizuki M: Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998;17:77-98.
3. Casaroli-Marano RP, Pagan R, Vilaro S: Epithelial-mesenchymal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999;40:2062-2072.
4. Greenburg G, Hay ED: Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982;95:333-339.
5. Vidaurri-Leal J, Hohman R, Glaser BM: Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: A new approach to the study of proliferative vitreoretinopathy. Arch Ophthalmol 1984;102:1220-1223.
6. Kirchhof B, Kirchhof E, Ryan SJ, Sorgente N: Vitreous modulation of migration and proliferation of retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci 1989;30:1951-1957.
7. Champochairo PA, Jerdan JA, Glaser BM, Cardin A, Michels RG: Vitreous aspirates from patients with proliferative vitreoretinopathy stimulates retinal pigment epithelial cell migration. Arch Ophthalmol 1985;103:1403-1405.
8. Rezai KA, Lai WW, Farrokh-Siar L, Pearlman J, Shu Judy, Patel SC, Ernest JT: A new method of culturing and transferring iris pigment epithelium. Invest Ophthalmol Vis Sci 1997; 38:2255-2260.
9. Kelly DL, Rizzino A: DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol Reprod Dev 2000;56:113-123.
10. Schulze A, Downward J: Navigating gene expression using microarrays - a technology review. Nat Cell Biol 2001;3:E191-195.
11. Ishida K, Yoshimura N, Yoshida M, Honda Y: Upregulation of transforming growth factor-β factor after panretinal photocoagulation. Invest Ophthalmol Vis Sci 1998;39:801-807.
12. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM: ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996;62:155-169.
13. Singh S, Zheng JJ, Peiper SC, McLaughlin BJ: Gene expression profile of ARPE-19 during repair of the monolayer. Graefes Arch Clin Exp Ophthalmol 2001;239:946-951.
14. Hunt D M, Chen W-H, Hunt RC: Vitreous treatment of retinal pigment epithelial cells results in decreased expression of FGF-2. Invest Ophthalmol Vis Sci 1998;39:2111-2120.
15. El-Asrar AMA, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, Missotten L: Monocyte chemotactic protein-1 in the proliferative vitreoretinal disorders. Am J Ophthalmol 1997;123:599-606.
16. Heidenkummer HP, Kampik A: Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes. Graefes Arch Clin Exp Ophthalmol 1992;230:483-487.
17. Kampik A, Kenyon K, Michels R, Green WR, de la Cruz ZC: Epiretinal and vitreous membranes. A comparative study of 56 cases. Arch Ophthalmol 1981;99:1445-1454.
18. Limb GA, Franks WA, Munasinghe KR, Chignell AH, Dumonde DC: Proliferative vitreoretinopathy: An examination of the involvement of lymphocytes, adhesion molecules, and HLA-DR antigen. Graefes Arch Clin Exp Ophthalmol 1993;231:331-336.
19. Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH: Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1999; 40:2453-2457.
20. Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT: Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649-3663.
21. Ko LJ, Shieh SY, ChenX, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ: p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol 1997;17:7220-7229.
22. Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A: p21CIP1 and Cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinase. Mol Cell Biol 1997; 17:4338-4345.
23. Zornig M, Evan GI: Cell cycle: On target with Myc. Curr Biol 1996;6:1553-1556.
24. Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A: Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1999;40:2683-2689.
25. Campochiaro PA, Hackett SF, Vinores SA: Growth factors in the retina and retinal pigmented epithelium. Prog Retin Eye Res 1996; 15:547-567.
26. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 1997;15:675-705.
27. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA: Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997; 81:919-926.
28. Guerrin M, Moukadiri H, Chollet P, Moro F, Datt K, Melecaze F, Plouet J: Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995;164:385-394.
29. Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, Saxena S, Gietz RD, Greenberg AH: The E1B 19K/Bcl-2-binding protein NIP3 is a dimeric mitochondrial protein that activates apoptosis. J Exp Med 1997;186:1975-1983.
30. Kamada S, Washida M, Hasegawa J, Kusano H, Funahashi Y, Tsujimoto Y: Involvement of caspase-4 (-like) protease in Fas-mediated apoptotic pathway. Oncogene 1997;15:285-290.
31. Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L: Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res 1998;58:76-83.
32. Cronstein BN, Weissmann G: The adhesion molecules of inflammation. Arthritis Rheum 1993;36:147-157.
33. Mackay CR, Imhof BA: Cell adhesion molecules in immune system. Immunol Today 1993;14:99-102.
34. Barile GR, Chang S, Park L, Reppucci VS, Schiff WM, Schmidt AM: Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 1999;19:219-227.
35. Adams DH, Lloyd AR: Chemokines: Leukocyte recruitment and activation cytokines. Lancet 1997;349:490-495.
36. Bian ZM, Elner SG, Strieter RM, Glass MB, Lukacs NW, Kunkel SL, Elner VM: Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cell. J Leukoc Biol 1996;60:405-414.
37. Bian ZM, Elner SG, Strieter RM, Kunkel SL, Lukacs NW, Elner VM: IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells. Curr Eye Res 1999;18:349-357.
38. Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel AL: Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci 1997;38:446-455.
39. Elner SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL: Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 1991;64:819-825.
40. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG: Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: Immunochemical and in-situ hybridization analysis. Exp Eye Res 1997;65:781-789.
41. Elner VM, Elner SG, Standiford TJ, Lukacs NW, Strieter RM, Kunkel SL: Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8. Exp Eye Res 1996;63:297-303.
42. Holtkamp GM, De Vos AF, Peek R, Kijlsta A: Analysis of secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-β2) by human retinal pigment epithelial cells. Clin Exp Immunol 1999;118:35-40.
43. Kurtz RM, Elner VM, Bian ZM, Strieter RM, Kunkel SL, Elner SG: Dexamethasone and cyclosporin a modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8. Invest Ophthalmol Vis Sci 1997;38:436-445.
44. Kato T, Ohno-Matsui K, Morita I, Tsuji M, Murata S, Mochizuki M: Dedifferentiation of retinal pigment epithelial cells induces monocyte chemoattractant protein-1 (MCP-1) gene expression through NK-κB transcription factor. Invest Opthalmol Vis Sci 2001;42:S762.